Argenta: 2021 Animal Health Investment Europe

About Argenta™
Founded in 2006 in New Zealand, Argenta’s talented and committed employees work on a daily basis to deliver excellence in animal health to customers around the world. With research and GMP manufacturing operations in New Zealand, the United States and the United Kingdom, Argenta holds a unique position as the only combined global contract research organization (CRO) and contract manufacturing organization (CMO) dedicated to animal health.

Argenta operates from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research & development, clinical research, regulatory, scale up and manufacturing needs along their veterinary product development journey.

The day-to-day ethos that drives Argenta forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of the business and the organisation is collaboration —among the global employee base and with their customers. Working together, Argenta continually challenges the status quo to continuing to innovate to develop the best animal health technologies and products possible.

From animal scientists to veterinarians to engineers and other industry experts, Argenta’s 450+ strong global team is a passionate and diverse group united in their commitment to healthy animals. The company operates from Research & Development locations in New Zealand and the US and (EMA and FDA) GMP approved Manufacturing sites in New Zealand, the United Kingdom (Scotland) and the United States (Fort Dodge, Iowa).

Argenta proudly partners with a vast range of global clients —from small and medium-sized enterprises to the largest industry players. The R&D capabilities and manufacturing facilities scale to service the requirements of the largest multinationals, while, at the other end of the spectrum, Argenta works with startups and small companies by offering capabilities and solutions that help bring their ideas to fruition.

For more information, please visit www.argentaglobal.com

Book our Roundtable sessions through the Networking Tab:

Monday and Tuesday at 3.30pm ***Limited places available***

Innovation through Partnership: Expanding your R&D Capabilities

Assessing the value of outsourcing (parts of) the product development process through external partnerships.

Advancing pipeline candidates while minimising operational costs: outsourcing value creation steps to innovate at scale.
Licensing existing innovative drug delivery technologies (IP) to kickstart your new compound or extend the product lifecycle of existing products.